This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The event brought together over 330 professionals from across the industry’s value chain PharmaceuticalManufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. Among the attendees, contract manufacturing organisations, service providers and experts were present.
Spanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond, it offers a comprehensive platform for stakeholders to engage in transformative dialogues and foster strategic partnerships. With exports nearing $27.84
Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceuticalmanufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.
Venkatesh, who is responsible for sterile injectable manufacturing and operations within Dr Reddy’s global organisation, also emphasises the role of data analytics, artificial intelligence, and low-cost automation in sterile manufacturing. The third issue in sterile manufacturing is the impact of human beings.
Fette Compacting Machinery India, Ace Technologies & Packaging Systems, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare, Venkata Narayana Active Ingredients, Unilab Chemicals and Pharmaceuticals, and many others. A vaccinemanufacturing powerhouse, India leads by supplying over 60 per cent of global vaccine demand.
Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4
India’s pharmaceutical industry is a global powerhouse. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. There have been persistent concerns about AMR being aggravated by effluents from pharmaceuticalmanufacturing plants.
International companies investing in the emerging market of Brazilian pharmaceuticalmanufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.
Pharmaceutical and biotechnology industries widely use freeze-drying systems to protect vaccines, antibodies, antibiotics such as penicillin, blood plasma, proteins, enzymes, hormones, viruses, and bacteria from heat and minimise their biological activity.
Given this dependence on foreign manufacturers, the African Union made regional production a central pillar of its New Public Health Order, and partnerships that support African-produced medicines, vaccines, and other medical products, are central to their efforts.
For example, a pharmaceutical brand can face increased acquisition costs if a supplier has not delivered on time. It also bears extra replacement expenses when drugs are discarded due to improper packaging. Technologies allow pharmaceutical companies to collect and analyze a massive amount of data to ensure proper drug safety.
In addition to standards for active pharmaceutical ingredients, USP also develops standards for the inactive ingredients (excipients) and other raw materials used in drug manufacturing. In a 2019 report on drug shortages, the FDA found that 62% of drug shortages occur because of quality issues in manufacturing.
A pharmaceutical warehouse is responsible for receiving, storing, and releasing incoming goods (including labeling and packaging) and distributing finished products. These regulations recognize that product quality can be significantly impacted if manufacturing and packaging have taken place.
To ensure the uninterrupted supply of ultra-pure excipients, Clariant has combined the global expertise of Clariant International (Switzerland) with local manufacturing capabilities in India to offer customised solutions for the evolving needs of the pharmaceutical industry.
To keep the EU’s medicine supply intact, Gupta suggests governments should adopt new pricing policies and provide further aid to mitigate the impact of rising operational costs; they should also minimise the exodus of generics manufacturers. Nonetheless, shortages can also result from a mismatch between supply and demand.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content